Roche

Can Roche Handle the Truth? “A Few Good Men” Case Could Expose Acne Drug Dangers
BNET Pharma
Mon, 08/2/10 - 08:12 pm
Roche
Accutane
3 Development-Stage Drugmakers Worth Watching
Motley Fool
Sun, 08/1/10 - 02:29 pm
InterMune
Medivation
Exelixis
Bristol-Myers Squibb
GSK
Roche
Seattle Genetics
Regeneron
Big Biotech: End of an Era
Seeking Alpha
Wed, 07/28/10 - 10:17 am
Alexion
Amgen
Amylin
Biogen Idec
Biomarin
Celgene
Genentech
Dendreon
Genzyme
Gilead Sciences
GSK
Roche
Human Genome Sciences
Vertex Pharmaceuticals
Sanofi
Roche Receives FDA Clearance For CoaguChek XS Pro System With Bar Code Reader For PT/INR Testing At The Point Of Care
Tue, 07/27/10 - 08:01 am
Roche
CoaguChek XS Pro System
Pfizer Halts Trial of Pain Drug: Biotech's Latest Mishaps
Seeking Alpha
Mon, 07/26/10 - 10:48 am
Pfizer
GSK
Novartis
Roche
Theratechnologies
Times Are A-Changing and Tough, Says Roche
InVivo
Fri, 07/23/10 - 07:28 am
Roche
Severin Schwan
Pharma CEOs
Roche Profit Up on Genentech Synergies
NY Times, NY
Thu, 07/22/10 - 08:53 am
Roche
earnings
M&A
Genentech
Avastin Breast Cancer Vote Signals Tough Environment For Drug Companies
Forbes
Wed, 07/21/10 - 07:59 am
Roche
breast cancer
Avastin
targeted therapeutics
cancer
Swine Flu Fizzles Out; WHO May Declare End to Pandemic Alert
Bloomberg
Tue, 07/20/10 - 11:01 am
WHO
swine flu
H1N1
GSK
Roche
Sanofi
Roche's Avastin Not as Good in New Studies as Early Data Showed, FDA Says
Bloomberg
Fri, 07/16/10 - 08:23 am
FDA
Avastin
Roche
breast cancer
Lilly, Roche dive deep into diagnostics
Wed, 07/14/10 - 02:49 pm
Eli Lilly
Roche
diagnostics
Genentech's New Option for Breast Cancer Patients
Seeking Alpha
Sun, 07/11/10 - 02:31 pm
Genentech
breast cancer
Immunogen
Roche
Trastuzumab-Dm1
FDA Clears Roche's LightCycler(R) MRSA Advanced Test For Use In The U.S.
Sat, 07/10/10 - 11:47 am
Roche
LightCycler
MRSA
Biotech Stock Mailbag: Somaxon
TheStreet.com
Fri, 07/9/10 - 12:27 pm
Somaxon
Dendreon
Arena Pharmaceuticals
Orexigen
Vivus
Roche
GSK
Immunogen
Avastin gets new thumbs-down at NICE
Fierce Pharma
Fri, 07/9/10 - 11:42 am
NICE
Avastin
UK
Roche
cancer
Affymax Sell-Off: Did Investors Overreact?
Seeking Alpha
Thu, 07/8/10 - 09:27 am
Affymax
Amgen
Takeda
EPO
Epogen
Micera
Roche
investors
Roche submits breast cancer drug for FDA approval
Reuters
Wed, 07/7/10 - 08:59 am
Roche
breast cancer
FDA
Trastuzumab-Dm1
Drug Companies' Investment Appeal
Smart Money
Wed, 06/30/10 - 08:39 am
Pfizer
Merck
Eli Lilly
Bristol-Myers Squibb
Novartis
Roche
AstraZeneca
GSK
Sanofi
Analysts turn bearish on Roche's taspoglutide prospects
Fierce Biotech
Tue, 06/29/10 - 09:17 am
diabetes
taspoglutide
analysts
Roche
Roche’s Taspoglutide Works Better Than Lantus, Byetta in Trials
BusinessWeek
Sat, 06/26/10 - 10:29 am
Roche
taspoglutide
Sanofi
Eli Lilly
Amylin
Byetta
Merck
Januvia
diabetes

Pages